These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19296597)

  • 1. N(epsilon)-thioacetyl-lysine-containing tri-, tetra-, and pentapeptides as SIRT1 and SIRT2 inhibitors.
    Kiviranta PH; Suuronen T; Wallén EA; Leppänen J; Tervonen J; Kyrylenko S; Salminen A; Poso A; Jarho EM
    J Med Chem; 2009 Apr; 52(7):2153-6. PubMed ID: 19296597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxadiazole-carbonylaminothioureas as SIRT1 and SIRT2 inhibitors.
    Huhtiniemi T; Suuronen T; Rinne VM; Wittekindt C; Lahtela-Kakkonen M; Jarho E; Wallén EA; Salminen A; Poso A; Leppänen J
    J Med Chem; 2008 Aug; 51(15):4377-80. PubMed ID: 18642893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a cell-active non-peptide sirtuin inhibitor containing N-thioacetyl lysine.
    Suzuki T; Asaba T; Imai E; Tsumoto H; Nakagawa H; Miyata N
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5670-2. PubMed ID: 19700324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N(epsilon)-Modified lysine containing inhibitors for SIRT1 and SIRT2.
    Huhtiniemi T; Suuronen T; Lahtela-Kakkonen M; Bruijn T; Jääskeläinen S; Poso A; Salminen A; Leppänen J; Jarho E
    Bioorg Med Chem; 2010 Aug; 18(15):5616-25. PubMed ID: 20630764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism-based inhibition of Sir2 deacetylases by thioacetyl-lysine peptide.
    Smith BC; Denu JM
    Biochemistry; 2007 Dec; 46(50):14478-86. PubMed ID: 18027980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human sirtuins by in situ generation of an acetylated lysine-ADP-ribose conjugate.
    Asaba T; Suzuki T; Ueda R; Tsumoto H; Nakagawa H; Miyata N
    J Am Chem Soc; 2009 May; 131(20):6989-96. PubMed ID: 19413317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect.
    Lara E; Mai A; Calvanese V; Altucci L; Lopez-Nieva P; Martinez-Chantar ML; Varela-Rey M; Rotili D; Nebbioso A; Ropero S; Montoya G; Oyarzabal J; Velasco S; Serrano M; Witt M; Villar-Garea A; Imhof A; Mato JM; Esteller M; Fraga MF
    Oncogene; 2009 Feb; 28(6):781-91. PubMed ID: 19060927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in silico approach to discovering novel inhibitors of human sirtuin type 2.
    Tervo AJ; Kyrylenko S; Niskanen P; Salminen A; Leppänen J; Nyrönen TH; Järvinen T; Poso A
    J Med Chem; 2004 Dec; 47(25):6292-8. PubMed ID: 15566299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-(3-(4-Hydroxyphenyl)-propenoyl)-amino acid tryptamides as SIRT2 inhibitors.
    Kiviranta PH; Leppänen J; Rinne VM; Suuronen T; Kyrylenko O; Kyrylenko S; Kuusisto E; Tervo AJ; Järvinen T; Salminen A; Poso A; Wallén EA
    Bioorg Med Chem Lett; 2007 May; 17(9):2448-51. PubMed ID: 17329104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nepsilon-thioacetyl-lysine: a multi-facet functional probe for enzymatic protein lysine Nepsilon-deacetylation.
    Fatkins DG; Monnot AD; Zheng W
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3651-6. PubMed ID: 16697640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a small molecule SIRT2 inhibitor with selective tumor cytotoxicity.
    Zhang Y; Au Q; Zhang M; Barber JR; Ng SC; Zhang B
    Biochem Biophys Res Commun; 2009 Sep; 386(4):729-33. PubMed ID: 19559674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic peptide-based potent and selective SIRT1/2 dual inhibitors harboring N
    Chen D; Zheng W
    Bioorg Med Chem Lett; 2016 Nov; 26(21):5234-5239. PubMed ID: 27707605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple N(ε)-thioacetyl-lysine-containing cyclic peptides exhibiting highly potent sirtuin inhibition.
    Huang Y; Liu J; Yan L; Zheng W
    Bioorg Med Chem Lett; 2016 Mar; 26(6):1612-1617. PubMed ID: 26874402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N(epsilon)-methanesulfonyl-lysine as a non-hydrolyzable functional surrogate for N(epsilon)-acetyl-lysine.
    Jamonnak N; Fatkins DG; Wei L; Zheng W
    Org Biomol Chem; 2007 Mar; 5(6):892-6. PubMed ID: 17340003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N,N'-Bisbenzylidenebenzene-1,4-diamines and N,N'-Bisbenzylidenenaphthalene-1,4-diamines as Sirtuin Type 2 (SIRT2) Inhibitors.
    Kiviranta PH; Leppänen J; Kyrylenko S; Salo HS; Lahtela-Kakkonen M; Tervo AJ; Wittekindt C; Suuronen T; Kuusisto E; Järvinen T; Salminen A; Poso A; Wallén EA
    J Med Chem; 2006 Dec; 49(26):7907-11. PubMed ID: 17181175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity studies on suramin analogues as inhibitors of NAD+-dependent histone deacetylases (sirtuins).
    Trapp J; Meier R; Hongwiset D; Kassack MU; Sippl W; Jung M
    ChemMedChem; 2007 Oct; 2(10):1419-31. PubMed ID: 17628866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of thieno[3,2-d]pyrimidine-6-carboxamides as potent inhibitors of SIRT1, SIRT2, and SIRT3.
    Disch JS; Evindar G; Chiu CH; Blum CA; Dai H; Jin L; Schuman E; Lind KE; Belyanskaya SL; Deng J; Coppo F; Aquilani L; Graybill TL; Cuozzo JW; Lavu S; Mao C; Vlasuk GP; Perni RB
    J Med Chem; 2013 May; 56(9):3666-79. PubMed ID: 23570514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human SIRT3 tripeptidic inhibitors containing N(ε)-thioacetyl-lysine.
    Chen B; Wang J; Huang Y; Zheng W
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3481-7. PubMed ID: 26220157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirtuin inhibitors.
    Alcaín FJ; Villalba JM
    Expert Opin Ther Pat; 2009 Mar; 19(3):283-94. PubMed ID: 19441904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based design of pseudopeptidic inhibitors for SIRT1 and SIRT2.
    Huhtiniemi T; Salo HS; Suuronen T; Poso A; Salminen A; Leppänen J; Jarho E; Lahtela-Kakkonen M
    J Med Chem; 2011 Oct; 54(19):6456-68. PubMed ID: 21895016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.